Eric Schadt is Mount Sinai Professor in Predictive Health and Computational Biology at the Icahn School of Medicine in New York City. He is also founder and chief executive officer of the predictive health company Sema4.
Eric Schadt
Professor
Icahn School of Medicine at Mount Sinai
From this contributor
Counseling can ease shock of unexpected genetic results
The best way to deliver surprises from genetic findings is to provide adequate information and counseling alongside the results.
Counseling can ease shock of unexpected genetic results
By
Eric Schadt
23 October 2018 | 6 min read
Explore more from The Transmitter
University probe leads to retraction of four neural tube studies
The University of Maryland conducted an internal investigation that identified image duplications and other data integrity issues in the studies, according to the retraction notices.
University probe leads to retraction of four neural tube studies
The University of Maryland conducted an internal investigation that identified image duplications and other data integrity issues in the studies, according to the retraction notices.
By
Claudia López Lloreda
16 October 2026 | 6 min read
Highly cited autism paper earns expression of concern over data duplications
The notice, published in Nature last week, also addressed an image duplication identified by a prominent research-integrity sleuth.
Highly cited autism paper earns expression of concern over data duplications
The notice, published in Nature last week, also addressed an image duplication identified by a prominent research-integrity sleuth.
By
Madeline Shaw
16 October 2026 | 4 min read
Govern neurodata by how it’s used, not where it’s from
New neurodata laws will shape how researchers gather, share and reuse brain data. A use-based governance protects basic researchers and those whose data are being used, without freezing science.
Govern neurodata by how it’s used, not where it’s from
New neurodata laws will shape how researchers gather, share and reuse brain data. A use-based governance protects basic researchers and those whose data are being used, without freezing science.
By
José M. Muñoz
16 October 2026 | 7 min read